Search

everythinglearnresearchcommunity

for

Search:↓

A new gene variant causes glucocorticoid resistance in a mother and son.

Most women with excessive hair growth have a hormonal cause.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Estrogens and progesterone are key in regulating melasma pigmentation.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Valproate can cause hair problems, but there are ways to manage them.

The skin produces and processes hormones, affecting both local and overall body functions.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.